Shares of Teladoc Health Inc. (TDOC) soared 5.22% on November 1st, after the telehealth company reported better-than-expected third-quarter earnings results. The stock gained despite analysts' mixed reactions and concerns over Teladoc's revenue outlook.
For the third quarter, Teladoc reported revenue of $641 million, in line with analysts' expectations. However, the company posted a smaller-than-anticipated loss of $0.19 per share, beating estimates and fueling the stock rally.
Following the results, some analysts slightly raised their earnings forecasts for 2025, but maintained a cautious stance on the company's prospects. Deutsche Bank, for instance, lifted its price target on Teladoc to $12 from $10 but kept a "Hold" rating, citing uncertainty over the company's future performance.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。